2009 Form 990-PF - Bill & Melinda Gates Foundation

BILL & MELINDA GATES FOUNDATION 56-2618866
FORM 990PF, PART XV - GRANTS AND CONTRIBUTIONS PAID DURING THE YEAR
RELATIONSHIP TO SUBSTANTIAL CONTRIBUTOR
AND
ATTACHMENT 18 (CONT'D)
RECIPIENT NAME AND ADDRESS FOUNDATION STATUS OF RECIPIENT PURPOSE OF GRANT OR CONTRIBUTION AMOUNT
2030 BECKER DRIVE 509(A)(1)
LAWRENCE, KS 66047
CELLS, AND TEST IT FOR ITS ABILITY TO INDUCE
ANTIBODY RESPONSE.
U OF KENTUCKY RESEARCH FOUNDATION NONE TO ELIMINATE LYMPHATIC FILARIASIS (LF) IN THE
1,311,669.
216 KINKEAD HALL 509(A)(3) TYPE 1
LEXINGTON, KY 405060057
SOUTH PACIFIC, USING ANTI-VECTOR APPROACHES
THAT WILL DIRECTLY IMPACT DENGUE TRANSMISSION
AND ARE TRANSFERABLE TO MULTIPLE
MOSQUITO-BORNE DISEASE
U OF MARYLAND BALTIMORE FOUNDATION NONE TO SUPPORT THE 12TH ANNUAL INTERNATIONAL
50,000.
110 SOUTH PACA STREET 509(A)(1)
THIRD FLOOR
BALTIMORE, MD 21201
MEETING OF THE INSTITUTE OF HUMAN VIROLOGY:
CELEBRATING 25 YEARS AFTER DISCOVERING HIV AS
THE CAUSE OF AIDS
U OF MASSACHUSETTS WORCESTER NONE JINHEE LEE AND GARY OSTROFF OF THE UNIVERSITY
100,000.
55 LAKE AVENUE NORTH 170(C)(1)
WORCESTER, MA 01655
OF MASSACHUSETTS MEDICAL SCHOOL IN THE U.S.
WILL TEST THE IDEA OF DELIVERING SMALL
INTERFERING RNA (SIRNAS) VIA GLUCAN PARTICLES
IN AN ORAL TB VACCINE FORMULATION. THE TEAM
WILL UTILIZE THE SIRNAS' ABILITY TO BLOCK
IMMUNOSUPPRESSIVE SIGNALING AND AMPLIFY THE
IMMUNE RESPONSE.
U OF MASSACHUSETTS WORCESTER NONE TO BETTER UNDERSTAND THE ROLE THAT
100,000.
55 LAKE AVENUE NORTH 170(C)(1)
WORCESTER, MA 01655
FOR PUBLIC DISCLOSURE
277 OF 519
ANTIMICROBIAL PEPTIDES PLAY IN THE IMMUNE
SYSTEM, GREGORY TEW OF THE UNIVERSITY OF
MASSACHUSETTS AMHERST IN THE U.S. WILL TEST
SYNTHETIC MOLECULES THAT MIMIC THESE PEPTIDES
FOR THEIR ABILITY TO CLEAR BACTERIA BY
ENGAGING THE INNATE AND ADAPTIVE IMMUNE SYSTEM.
ATTACHMENT 18